To Compare the Efficacy and Safety of BP102 vs. Avastin® in Combination With Paclitaxel/Carboplatin in First-line Treatment of Advanced or Relapsed NSCLC
Clinical trial NCT05169801 · COMPLETED
Trial details
- NCT number
- NCT05169801
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-25
- Primary completion
- 2019-10-21
- Enrollment
- 520
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.